awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36892821-688D9F45-803C-4E08-BF9B-2241188D597D
Q36892821-688D9F45-803C-4E08-BF9B-2241188D597D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-688D9F45-803C-4E08-BF9B-2241188D597D
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
P2860
Q36892821-688D9F45-803C-4E08-BF9B-2241188D597D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-688D9F45-803C-4E08-BF9B-2241188D597D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a295dd6891a40f8126990f7ffec7a75c3ebbb2b
P2860
Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models.